Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-12 12:26 pm Unchanged |
2024-09-30 | 13G | Accolade, Inc. ACCD |
The Vanguard Group | 4,157,154 5.190% |
0 (Unchanged) |
Filing History |
2024-11-12 12:14 pm Unchanged |
2024-09-30 | 13G | 23andMe Holding Co. ME |
The Vanguard Group | 15,569,830 4.580% |
0 (Unchanged) |
Filing History |
2024-11-12 12:14 pm Unchanged |
2024-09-30 | 13G | Achieve Life Sciences, Inc. ACHV |
The Vanguard Group | 1,940,388 5.650% |
0 (Unchanged) |
Filing History |
2024-11-12 12:13 pm Unchanged |
2024-09-30 | 13G | 3D Systems Corporation DDD |
The Vanguard Group | 7,492,383 5.600% |
0 (Unchanged) |
Filing History |
2024-11-12 12:13 pm Unchanged |
2024-09-30 | 13G | AAON, Inc. AAON |
The Vanguard Group | 6,163,650 7.600% |
0 (Unchanged) |
Filing History |
2024-11-12 12:13 pm Unchanged |
2024-09-30 | 13G | ACCO Brands Corporation ACCO |
The Vanguard Group | 6,263,499 6.530% |
0 (Unchanged) |
Filing History |
2024-11-12 12:13 pm Unchanged |
2024-09-30 | 13G | Acelyrin, Inc. SLRN |
The Vanguard Group | 4,066,989 4.070% |
0 (Unchanged) |
Filing History |
2024-11-12 12:12 pm Unchanged |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
The Vanguard Group | 2,767,717 5.320% |
0 (Unchanged) |
Filing History |
2024-11-12 12:12 pm Unchanged |
2024-09-30 | 13G | A-Mark Precious Metals, Inc. AMRK |
The Vanguard Group | 1,312,460 5.710% |
0 (Unchanged) |
Filing History |
2024-11-07 10:52 am Purchase |
2024-10-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
The Vanguard Group | 20,730,939 10.020% |
424,343![]() (+2.09%) |
Filing History |
2024-11-07 10:52 am Purchase |
2024-10-31 | 13G | Matador Resources Company MTDR |
The Vanguard Group | 12,498,860 10.010% |
1,477,868![]() (+13.41%) |
Filing History |
2024-11-07 10:52 am Purchase |
2024-10-31 | 13G | Curbline Properties Corp. CURB |
The Vanguard Group | 13,210,431 12.590% |
13,210,431![]() (New Position) |
Filing History |
2024-11-07 10:25 am Unchanged |
2024-09-30 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
The Vanguard Group | 20,306,596 9.810% |
0 (Unchanged) |
Filing History |
2024-11-04 3:33 pm Unchanged |
2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH |
The Vanguard Group | 2,051,689 4.190% |
0 (Unchanged) |
Filing History |
2024-11-04 3:32 pm Unchanged |
2024-09-30 | 13G | Klaviyo, Inc. KVYO |
The Vanguard Group | 7,075,227 9.740% |
0 (Unchanged) |
Filing History |
2024-11-04 3:28 pm Unchanged |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 5,760,449 9.430% |
0 (Unchanged) |
Filing History |
2024-11-04 3:27 pm Unchanged |
2024-09-30 | 13G | Virgin Galactic Holdings, Inc. SPCE |
The Vanguard Group | 1,217,652 4.270% |
0 (Unchanged) |
Filing History |
2024-11-04 3:24 pm Unchanged |
2024-09-30 | 13G | Stem, Inc. STEM |
The Vanguard Group | 8,655,953 5.320% |
0 (Unchanged) |
Filing History |
2024-11-04 3:23 pm Unchanged |
2024-09-30 | 13G | Rush Street Interactive, Inc. RSI |
The Vanguard Group | 7,539,851 9.070% |
0 (Unchanged) |
Filing History |
2024-11-04 3:22 pm Unchanged |
2024-09-30 | 13G | Rocket Lab USA, Inc. RKLB |
The Vanguard Group | 35,527,484 7.150% |
0 (Unchanged) |
Filing History |